Clinical Study

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study To Assess The Efficacy And Safety Of Oral Bps-314D-Mr Added-On To Treprostinil, Inhaled (Tyvaso®) In Subjects With Pulmonary Arterial Hypertension

Posted Date: May 26, 2017

  • Investigator: Jean Elwing
  • Co-Investigator: Jean Elwing
  • Specialties: Lung Disease, Pulmonary Diseases
  • Type of Study: Drug

The purpose of this study is to compare the effect of an oral (by mouth) prostanoid to placebo, when both are used with inhaled Tyvaso. The study will also evaluate the safety of this prostanoid. This study will also keep track of changes in your exercis

Criteria:

You Are Being Asked To Take Part In This Research Study Because You Have Pulmonary Arterial Hypertension (Pah), Which Means That You Have High Blood Pressure In Your Lungs. In Addition, Your Doctors Have Determined That Based On Your Current Pah Conditio

Keywords:

Lung Disease, Pah, Pulmonary, Pulmonary Arterial Hypertension , Shortness Of Breath

For More Information:

Melissa Banuelos
(513) 558-2187
banuelma@ucmail.uc.edu

  • Search Clinical Studies

  • Research in the News

    UC Study Finds Organs from HCV Donors May Be Safe for Liver Transplant

    A UC researcher says livers from HCV patients who test positive for theantibody made to fight the disease may pose a modest risk of infection and beacceptable for transplant